• FDA warns companies selling kratom products on opioid addiction claims

    FDA warns companies selling kratom products on opioid addiction claims0

    (Reuters) – The U.S. Food and Drug Administration issued warning letters on Tuesday to two privately held companies for illegally selling unapproved, misbranded drugs containing kratom claiming to cure opioid addiction and withdrawal symptoms.

    Leaves of the kratom tree, native to southeast Asia, can be used as a stimulant or sedative and the U.S. Drug Enforcement Administration has listed it as a “drug and chemical of concern”.

    The FDA warning letters were issued to Cali Botanicals and Kratom NC. Both the companies did not immediately respond to requests for comment.

    Advocates say kratom helps ease pain and reduce symptoms of opioid withdrawal, but the FDA has not approved it for any medical use.

    Continue reading.
    READ MORE
  • Ethema Signs LOI

    Ethema Signs LOI0


    West Palm Beach, FL, May 28, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Ethema Health Corporation (OTCQB:GRST) (“Ethema” “GRST” or the “Company”), a provider of healthcare services, today announced that it has agreed to a letter of intent to purchase an interest in IC Pharma, LLC and its group of companies.… Continue reading.

    READ MORE
  • Arizona lawmakers poised to approve kratom regulations

    Arizona lawmakers poised to approve kratom regulations0

    Lawmakers are planning to regulate a substance called kratom that is still undergoing evaluations by federal agencies, such as the Drug Enforcement Agency and the Food and Drug Administration, and has been making medical professionals nervous.

    The measure, sponsored by Rep. Tony Rivero, R-Peoria, would disallow the sale of kratom to anyone under the age of 18 and requires sellers of the product to disclose what all is in their kratom based products on top of other regulatory measures.

    Rivero calls it the “Kratom Consumer Protection Act.”

    Arizona is not alone in how it is trying to tackle regulation of a new drug that is mostly unknown and has entities like the Center for Disease Control and the Drug Enforcement Agency working to determine how to deal with it.

    Continue reading.
    READ MORE